Search company, investor...


Other Investors | Alive

About FasT Biopharma

FasT Biopharma specializes in the development of candidate therapeutics in the biopharmaceutical industry. The company's main focus is on creating treatments that block a major pathway involved in the unwanted death of cells, aiming to provide potential breakthrough therapies for a range of diseases. These therapies are designed to prevent apoptotic cell death, which has implications for conditions such as blindness, cancer, immune failure, diabetes, and lung fibrosis. It is based in Oxfordshire, England.

Headquarters Location

10 Aston Park Aston Rowant, Oxfordshire

Oxfordshire, England, OX49 5SW,

United Kingdom



FasT Biopharma Frequently Asked Questions (FAQ)

  • Where is FasT Biopharma's headquarters?

    FasT Biopharma's headquarters is located at 10 Aston Park, Oxfordshire.

  • What is FasT Biopharma's latest funding round?

    FasT Biopharma's latest funding round is Other Investors.

  • Who are the investors of FasT Biopharma?

    Investors of FasT Biopharma include Alderley Park Ventures.



CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.